Pharmacotherapy of Gastrointestinal Inflammation
In recent years, the area of pharmacotherapy of GI inflammation has witnessed important progress, with new drugs and therapeutic approaches being introduced. The volume reviews the pharmacotherapy of selected gastrointestinal inflammatory conditions chose
- PDF / 16,585,050 Bytes
- 152 Pages / 439.37 x 666.142 pts Page_size
- 94 Downloads / 192 Views
Series Editor Prof. Dr. Michael J. Parnham Senior Scientific Advisor PUVA dd Prilaz baruna Filipovica 25 10000 Zagreb Croatia
Advisory Board G. Z. Feuerstein (Merck Research Laboratories, West Point, PA, USA M. Pairet (Boehringer Ingelheim Pharma KG, Biberach a. d. Riss, Germany) W van Eden (Universiteit Utrecht, Utrecht, The Netherlands)
Forthcoming titles: Arachidonate Remodeling and Inflammation, AN. Fonteh, R.L. Wykle (Editor), 2003 Cancer and Inflammation, D.W Morgan, U. Forssmann, M. Nakada (Editors), 2003 Recent Advances in Pathophysiology of COPD, P.J. Barnes, T.T. Hansel (Editors), 2003 Antirheumatic Therapy: Actions and Outcomes, R.O. Day, D.E. Furst, P.L. van Riel (Editors), 2003 Cytokines and Joint Injury, P. Miossec, WB. van den Berg (Editors), 2004 Antibiotics as Anti-inflammatory and Immunomodulatory Agents, B. Rubin, J. Tamaoki (Editors), 2004 (Already published titles see last page.)
Pharmacotherapy of Gastrointestinal Inflammation
Antonio Guglietta Editor
Springer Basel AG
Editor Antonio Guglietta R&D Direclor Grupo Ferrer Internacional c./Juan de Sada 32 08028 Barcelona Spain
A CIP catalogue record for this book is available from the Library of Congress, Washington D.C., USA
Bibliographic information published by Die Deutsche Bibliothek Die Deutsche Bibliothek lists this publication in the Deutsche Nationalbibliografie; detailed bibliographic data is available in the internet at http://dnb.ddb.de
The publisher and editor can give no guarantee for the information on drug dosage and administration contained in this publication. The respective user must check its accuracy by consulting other sources of reference in each individual case. The use of registered names, trademarks etc. in this publication, even if not identified as such, does not imply that they are exempt from the relevant protective laws and regulations or free for general use.
This work is subject to copyright. AII rights are reserved, whether the whole or part of the material is concerned, specifically the rights of lranslation, reprinting, re-use of illustrations, recitation, broadcasting, reproduclion on microfilms or in other ways, and storage in data banks. For any kind of use, permission of the copyright owner must be obtained.
© 2004 Springer Sasel AG Originally published by Sirkhauser Verlag in 2004 Softcover reprint of the hardcover 1st edition 2004 Printed on acid-free paper produced from chlorine-free pulp. TCF ~ Cover design: Markus Etterich, Basel Cover illustration: Legend to figure see p. 125. Reprinted from: lIan Y, Weksler-Zangen 5, Ben-Horin 5, Diment J, Sa uter B, Rabbani E, Engelhardt D, Roy Chowdhury N, Roy Chowdhury J, Goldin E (2000) Treatment of experimental colitis by oral tolerance induction: A central role for suppressor Iymphocytes. Am J Gastroenterology 95: 966-973, with permission from American Col lege of Gastroenterology ISBN 978-3-0348-9625-2 ISBN 978-3-0348-7930-9 (eBook) DOI 10.10071978-3-0348-7930-9
987654321
www.birkhauser-science.com
Contents
List of contributors
vii
Preface
i
Data Loading...
